Endocrine toxicity of immune checkpoint inhibitors: a network meta-analysis of the current evidence
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment but pose a challenge of immune-related adverse events (irAEs), particularly endocrine toxicity, that can severely compromise patient well-being. Existing research has often been limited in scope and has not provided comprehensi...
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado: |
Compuscript Ltd
2024-01-01
|
| Series: | Acta Materia Medica |
| Acceso en liña: | https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2023-0037 |